T細胞の腫瘍誘導メガモレクルの合成と活性
Sraeyes Sridhar1, Justin A Modica1, Daniel J Sykora1
1Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, Illinois 60208, United States.
Journal of the American Chemical Society
|August 21, 2024
まとめ
研究者らは,HER2+ がんに対するT細胞の再誘導を目的とした新しい双特異性抗体の模倣剤を開発した. これらのMegaMoleculesはがん細胞を効果的に標的にし,臨床前のモデルでは腫瘍の減少につながります.
科学分野:
- バイオテクノロジー
- 免疫学
- 腫瘍学
背景:
- HER2陽性 (HER2+) がんは治療上の大きな課題となっています.
- 双特定抗体などのT細胞リダイレクト療法が 癌の治療において有望であることが示されています
- 強化されたT細胞の関与のための新しいフォーマットの開発は極めて重要です.
研究 の 目的:
- HER2+ がん治療のための新しい双特定抗体ミミカ (MegaMolecules) の合成と特徴づけ
- T細胞の誘導力に対するFab指向とスキャフォルド・バレンスの影響を評価する.
- 関連するがんモデルにおけるこれらの抗体模倣の in vivo 効果を評価する.
主な方法:
- 26のMegaMoleculeベースのバイスペシフィック抗体ミミックの合成と特徴付け.
- T細胞の募集,活性化,および腫瘍細胞溶解のインビトロ評価
- 立方体のバレンシーとファブ・オリエンテーションの効能への影響の評価
- HER2+乳がんのヒト化型異種移植モデルにおける in vivo有効性試験
主要な成果:
- HER2とCD3εを結合してT細胞を活性化させる機能的双特異メガモレキュルが開発されました.
- 効果は150倍に見られた.
- トリマーまでのスキャフォールド・バレンシーの増加は効力を改善し,それ以上の利益は減少した.
- 抗体ミミックはHER2+腫瘍の体積を in vivoで有意に減少させました.
結論:
- 二固有の抗体シミュレータは,HER2+がんに対するT細胞リダイレクトの有望な戦略を提供します.
- 治療効果を最大化するには,Fabの方向性とスキャフォルドのバレンシーを最適化することが重要です.
- ガン治療の新種となる可能性を 示しています
関連する概念動画
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
T Cell Activation and Clonal Selection
692
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
692
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
T Cell Types and Functions
963
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
963
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


